First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.
Abstract
This open-label, multi-center phase II study investigated the efficacy and safety of the combination of 5-fluorouracil (5-FU)/folinic acid (FA) plus gemcitabine (GFF) in patients with advanced pancreatic cancer. The study is based on our completed dose finding phase I trial.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 5 |
| ISSN | 0344-5704 |
| Publication status | Published - 2011 |
| pubmed | 21400239 |
|---|
